2025 2024 2023 2022 2021 2020 04.17.2025 / 【Company Topic】Synplogen has entered into a business alliance agreement with ARCALIS, Inc. to promote development and manufacturing of mRNA therapeutics and vaccines (Published: March 6, 2025） 04.16.2025 / 【Company Topic】MiCAN Establishes German Subsidiary for MylcMAT Deployment (Published: April 8, 2025） 03.25.2025 / 【Company Topic】Aeras Bio and RD Dental Clinic started Japan’s First Clinical Study on "Pulp Regeneration Treatment" Using Allogeneic Dental Pulp Stem Cells (Published: February 20, 2025） 03.21.2025 / 【Company Topic】Medicaroid Files for CE Mark Certification Under MDR for the hinotori™ Surgical Robot System (Published: March 11, 2025） 02.21.2025 / 【Company Topic】Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa (Published: February 13, 2025） 02.03.2025 / "Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages" : our research team’s findings published in Blood Online on February 1, 2025 02.03.2025 / 【Company Topic】VCCT Inc. and Japan Tissue Engineering Form a Capital and Business Alliance to Put iPS Cell-Based Regenerative Medical Products to Practical Use (Published: January 30, 2025） 01.21.2025 / 【Company Topic】Healios Concluded a Master Collaboration Agreement and License Option Agreement with Akatsuki Therapeutics Inc.（Published: January 20, 2025） 12.06.2024 / 【Company Topic】Sysmex and J-TEC Sign a Basic Agreement to Advance Manufacturing Capabilities for Regenerative Medicine and Cell Therapy（Published: December 5, 2024） 12.06.2024 / 【Company Topic】Signing ceremony for MoU between Cyto-Facto Inc. and Thermo Fisher Scientific Japan（Published: December 4, 2024） 11.20.2024 / 【Company Topic】Sysmex Announces First Overseas Product Introduction and Clinical Use of the hinotori™ Surgical Robot System- Accelerating Market Entry in Asia Pacific Region -（Published: November 6, 2024） 10.08.2024 / 【Company Topic】Celaid Therapeutics Inc. Secures up to $19M Grant from the Japanese Agency for Medical Research and Development (Published: September 30, 2024) 10.07.2024 / 【Company Topic】United Immunity published preclinical results on the efficacy and immunogenicity of next gen COVID-19 vaccine utilizing Myeloid Targeting Platform™ 10.07.2024 / 【KBIC Topic】KBIC will exhibit at BioJapan 2024! (Oct 9~11, 2024 in Yokohama) 09.27.2024 / 【Company Topic】Cyto-Facto Inc. has concluded Memorandum of Understanding (MOU) with SanBio Co, Ltd. (Published: September 19, 2024) 09.25.2024 / Three top winners of “Kansai Life Science Accelerator Program 2024” have been selected! 08.26.2024 / 【Company Topic】Tokyo Medical and Dental University and Celaid Therapeutics Inc. Joint Research Agreement on Research and Development of Gene-modified Cell Therapy Using Human Bone Marrow Hematopoietic Stem Cells (HSCs) (Published: August 21, 2024) 08.06.2024 / 【Company Topic】Sysmex Group’s Largest Manufacturing Base Completed in India (Published: August 1, 2024) 08.01.2024 / 【Company Topic】United Immunity enters into the Research Collaboration Agreement with AstraZeneca (Published: July 26, 2024) 07.24.2024 / 【Company Topic】World's First R&D Center for Biomanufacturing with Gas Fermentation to be Established at Port Island, Kobe by JGC Holdings Corporation (Published: July 17, 2024) 07.22.2024 / 【Company Topic】MiCAN Technologies concluded a joint research and development agreement with Miura Co., Ltd. (Published: June 26, 2024) 06.27.2024 / 【Company Topic】Healios Concluded License Agreement with Astellas Pharma Concerning RPE Cell Production Method (Published: June 19, 2024) 06.21.2024 / 【Company Topic】Sysmex’s PA-100 AST System for Rapid Detection of Antimicrobial Susceptibility Wins One of the UK’s Biggest Science Prizes “Longitude Prize on AMR” (Published: June 13, 2024) 05.22.2024 / 【Company Topic】Cyto-Facto Inc. has raised 1.18 billion Yen through third-Party allocation shares as Series A. (Published: April 22, 2024) 05.20.2024 / 【Company Topic】Celaid has raised 1.2 billion yen in its Series A financing round to advance HSC-based cell and gene therapies and platform (Published: May 8, 2024) 05.17.2024 / X-irradiated umbilical cord blood cells retain their regenerative effect in experimental stroke: FBRI's research team’s findings published in Scientific Reports on March 22, 2024 04.22.2024 / 【Company Topic】Synplogen Signs Business Alliance Agreement with FUJIFILM Toyama Chemical (Published: April 16, 2024) 04.05.2024 / 【Company Topic】IDDK Co., Ltd., a Space Bio-Experiment Service Provider, Raises USD 0.5M in Pre-Series A Second Close (Published: March 18, 2024) 04.03.2024 / 【Company Topic】United Immunity secures ￥180 million by Debt Financing from Aozora Corporate Investment (Published: March 18, 2024) 03.28.2024 / FBRI and Celaid Therapeutics have executed a collaborative research agreement for vascular regeneration products derived from human hematopoietic stem cells 03.27.2024 / 【Company Topic】Celaid Therapeutics was Chosen for the New Energy and Industrial Technology Development Organization (NEDO) Deep Tech Startup Support Project (DTSU) (Published: March 22, 2024) 03.19.2024 / 【Company Topic】Synplogen Signs Partner Marketing Agreement with Ginkgo Bioworks (Published: March 7, 2024) 03.13.2024 / 【Event Report】 KBIC hosted “Regenerative Medicine Industrialization Forum 2024 in Nihonbashi” on January 26th and attracted industry and academia in the field of Cell and Gene Therapy 03.12.2024 / 【Event/Seminar】MD in Japan:Navigating Opportunities in Software as a Medical Device for 2024 02.21.2024 / 【Company Topic】 Global Korean Company Celltrion, Inc. to start a partnership with Kobe Biomedical Innovation Cluster to promote Korean Startups’ Business Development in Japan and Around the World 02.21.2024 / 【Company Topic】 xCARE Inc. has raised 130 million yen through a third-party allocation of new shares on January 15, 2024 (Published: February 13, 2024) 02.13.2024 / 【Company Topic】Bayer Yakuhin held an event "Startup x Pharma Connect by Bayer in Kobe" co-hosted by Kobe City and FBRI to exchange opinions on activating the drug discovery innovation ecosystem with the drug discovery startups mainly based in Kansai 02.08.2024 / RNA Analysis of Circulating Leukocytes in Patients with Alzheimer’s Disease: FBRI’s research team’s findings published in Journal of Alzheimer's Disease on January 22, 2024 02.05.2024 / 【Event/Seminar】The 5th Kyoto University LifeScience Showcase @San Diego 2024 02.05.2024 / 【Company Topic】MiCAN Technologies Established a Development Office in Europe at Biolabs Heidelberg for the Development of an Alternative Thermogenic Test Product (MylcMAT) Using Human Immortalized Monocyte Cells (aMylc) (Published: January 17, 2024) 01.23.2024 / 【Company Topic】CarbGeM Launched Automated Gram Stainer “PoCGS®-Pro” in Japan (Published: January 10, 2024) 01.12.2024 / Announcement of Letter of Intent with Nobelpharma for the Development and Commercialization of HLCM051 for ARDS in Japan 12.25.2023 / BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state: FBRI's research team’s findings published in Nature Communications on December 16, 2023 12.20.2023 / 【Company Topic】Restore Vision Completes Series A Round Financing to Accelerate Global Development (Published: December 15, 2023) 12.18.2023 / 【Company Topic】United Immunity’s UI-102 has been selected by AMED as “Strengthening Program for Pharmaceutical Startup Ecosystem” (Published: December 5, 2023) 12.06.2023 / 【KBIC Topic】A “Bio Manufacturing Co-Creation Center” to be established at Kobe University in a project selected by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) 12.01.2023 / 【Company Topic】CellFiber raises US$5.5 million in funding from JAFCO and four other companies 11.30.2023 / 【Research Topic】Activation of neurogenesis in the hippocampus is a novel therapeutic target for Alzheimer's disease: FBRI's research team’s findings published in Neuroprotection on November 21, 2023 11.28.2023 / 【Company Topic】VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through Third-Party Allotment. Cumulative Funds Raised Amount to Approximately 1.7 billion yen (Approximately $11.3 million USD) 11.13.2023 / 【Company Topic】AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products - Securing the Manufacturing and Sales License for Regenerative Medicine Products Developed by JUNTEN BIO - (Published: November 7, 2023) 11.13.2023 / 【FBRI Topic】Kobe Biomedical Innovation Cluster (KBIC) will exhibit at MEDICA 2023, the world's largest international medical device exhibition 11.07.2023 / 【Company Topic】Demonstration of Remote Surgery Using the hinotori™ Surgical Robot System Successfully Performed Between Singapore and Japan 10.26.2023 /【Company Topic】Carna Biosciences Announces Clinical Trials.gov Registration for GS-9911 Phase 1 Study (Published: October 16, 2023) 09.25.2023 /【FBRI Topic】 KBIC will exhibit at Bio Japan 2023! (Oct 11~13, 2023 in Yokohama) 09.19.2023 / 【Company Topic】Healios eNK Cell Research by Thomas Jefferson University in Metastatic Uveal Melanoma 09.19.2023 / 【FBRI Topic】The Japanese MedTech & HealthTech Market 2023 Episode 2 : SaMD 09.19.2023 / 【Company Topic】United Immunity successfully completed fund raising and grant approval for more than 1.1 billion yen value (Published: September 11, 2023) 09.19.2023 / 【FBRI Topic】 Kobe Biomedical Innovation Cluster in BIOSPAIN 2023! (Sep 26-28, 2023, Barcelona) 09.06.2023 / 【Company Topic】emol and Department of Digital Mental Health, Graduate School of Medicine, The University of Tokyo Started Joint Research for Dissemination and Implementation of the iCBT Program (Published: August 10, 2023) 09.06.2023 / 【Company Topic】Total Brain Care Co. Ltd. Concluded a Joint Research Agreement with The University of Tokyo Graduate School of Medicine, Department of Digital Mental Health (Published: August 4, 2023) 08.28.2023 / 【FBRI Topic】 We will exhibit at Medical Fair Thailand 2023 (Sep 13-15, 2023, Bangkok) 08.21.2023 / 【Company Topic】 MiCAN Technologies has Raised 200 Million Yen Through the Third-Party Allocation of Shares (Published: August 7, 2023) 08.18.2023 / 【FBRI Topic】Three startups were selected to participate in the “Kansai Life Science Accelerator Program 2023” 08.10.2023 / 【Company Topic】Celaid Therapeutics Signed a Collaborative Research Agreement with National Cancer Center Japan (Published: August 3, 2023) 07.27.2023 / 【Research Topic】SETBP1 is dispensable for normal and malignant hematopoiesis: FBRI's research team’s findings published ‘Leukemia’ on July 18, 2023 07.21.2023 / 【Company Topic】AMI Inc. has raised 910 million JPY in Series B round financing (Published: June 6, 2023) 07.19.2023 / 【Company Topic】Healios and Saisei Ventures Enter into a Letter of Intent and Establish Subsidiary for eNK Research and Development (Published: July 11, 2023) 07.19.2023 / 【Company Topic】Healios and Saisei Ventures Enter into a Letter of Intent and Establish Subsidiary for ARDS Treatment Development (Published: July 6, 2023) 06.26.2023 / 【Company Topic】Restore Vision Closes Series A Round Funding Aims to Begin First-in-Human Study in 2024 (Published: June 5, 2023) 06.12.2023 / 【Company Topic】Submission of clinical trial notification for RPE tear using RPE cells derived from allogeneic iPS cells (HLCR011) (Published: May 25,2023) 05.29.2023 / 【Research Topic】Fugaku continues to achieve top rankings (Published: May 22nd , 2023) 05.19.2023 / 【Company Topic】Regulatory Approval Application Filed with the Health Sciences Authority in Singapore for the “hinotori™ Surgical Robot System” (Published: May 8th, 2023) 04.27.2023 / 【Company Topic】JCR and Sumitomo Pharma Enter into Co-Promotion Agreement in Japan for IZCARGO® I.V. Infusion 10 mg, a Recombinant Therapeutic for Mucopolysaccharidosis Type II(Published: April 6,2023) 04.01.2023 /【Company Topic】Sinfonia Technology’s CellQualia™ Intelligent Cell Processing System was featured on the official website of the British government 03.13.2023 /【Company Topic】Sysmex and Siemens Healthineers Establish Global Agreement to Supply Hemostasis Instruments and Reagents as OEMs(Published: March 8, 2023) 02.24.2023 /【Company Topic】VC Gene Therapy（VCGT Inc.）and Synplogen collaborate on process development for gene therapy of retinal degenerative diseases 02.21.2023 /【FBRI Topic】The Japanese MedTech & HealthTech Market 2023 01.16.2023 /【Research Topic】FBRI’s research group defined immunosuppressive anti-PD-1 antibodies and published in Science Immunology on January 13, 2023 12.27.2022 /【Company Topic】Carna Announces Successful Development of New Tablet Formulation of AS-0871（Published: December 20, 2022） 12.09.2022 /【Event/Seminar】Kansai Life Science Accelerator Program 2022 Innovation Showcase 12.05.2022 /【Research Topic】Supercomputer Fugaku Continues to Achieve Top Rankings (Published: November 17, 2022) 12.01.2022 /【Company Topic】JCR Pharmaceuticals Announced the Completion of Kobe Science Park Center for Manufacturing of Vaccines (Published: November 9, 2022) 11.29.2022 /【FBRI Topic】The Japanese MedTech & HealthTech Market 2022 11.17.2022 /【Company Topic】Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Gastroenterology and Gynecology (Published: October 13,2022) 10.07.2022 /【Company Topic】 Sysmex Launches the UF-1500 Fully Automated Urine Particle Analyzer, a New Product for the Urine Sediment Testing Field (Published: September 27, 2022) 10.07.2022 /【FBRI Topic】Kobe Biomedical Innovation Cluster (KBIC) will participate in BioJapan 2022 (Oct 12~14, 2022 in Yokohama) 10.07.2022 /【FBRI Topic】Three new startups to participate in the “Kansai Life Science Accelerator Program 2022” 08.23.2022 /【FBRI Topic】KBIC in Medical Fair Asia 2022, Singapore 07.21.2022 /【Company Topic】HEALIOS K.K. Exercises Exclusive Option for a License Agreement with STEMAXON for the Development of UDC-Derived Photoreceptor Cells (Published: July 12, 2022) 07.08.2022 /【Company Topic】Sysmex Announced the Completion of Declaration of Conformity to the European IVD Directive for an Assay Kit that Measures Plasma Amyloid Beta (Aβ) Using the Automated Immunoassay System HISCLTM-5000/HISCLTM-800 (Published: June 27, 2022) 07.01.2022 /【Research Topic】FBRI's research on Acute Myeloid Leukemia publish in “Blood” ~ Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia ~ 06.02.2022 /【Company Topic】Carna Announces Clearance of IND to Initiate Phase 1b Study of AS-1763 in the U.S.（Published: May 30, 2022） 05.16.2022 /【Company Topic】TreeFrog Therapeutic launches a $100,000 research grant in regenerative medicine 05.13.2022 /【Research Topic】FBRI’s research team elucidates a novel regulatory mechanisms by which MDS cells inhibit normal hematopoiesis, published in Cell Reports on May 10, 2022 05.11 2022 / 【Company Topic】Astrego Diagnostics AB Becomes Wholly-owned Sysmex Subsidiary through the Acquisition of Outstanding Shares (Published: May 2, 2022) 04.08 2022 / 【Company Topic】TreeFrog Therapeutics settles in Kobe to drive the adoption of new technology for the mass-production of iPS cell therapies 04.07 2022 / 【Company Topic】Evec, Inc. successfully developed monoclonal antibodies with SARS-CoV-2 viruses including the Omicron BA.2 variants 03.29.2022 / 【FBRI Topic】 The Complete Guide on How to Set Up Your Business in Japan 03.28 2022 / 【FBRI Topic】The MedTech Alliance MAGIA and FBRI build new connections Between Japan and Europe by signing a Joint collaboration agreement 02.28 2022 / 【Research Topic】New contract cell manufacturing facility has launched in Kobe Biomedical Innovation Cluster ~ A next-generation CPC-model facility ~ (Published: February 28, 2022) 02.24 2022 / 【Company Topic】Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences (Published: February 2, 2022) 02.14 2022 / Dr. Taguchi Akihiko of FBRI’s research was published in Frontiers in Aging Neuroscience (Published: February 3, 2022) 01.26 2022 / 【Company Topic】Sysmex and Yamato Transport Commence Dry Ice-Free Transportation of Reagents for Gene Testing in Consolidated Cargo at the Ultralow Temperature Range of Minus 70 Degrees Celsius (Published: December 23, 2021) 01.11 2022 / 【Company Topic】Bacchus Bio innovation Co., Ltd. contributes to solving societal issues through Smart Cell development (Published: December 1, 2021) 12.17 2021 / 【Healthcare Topic】Kobe City’s Age-Tech Eldercare Technology Implementation and Promotion Program Creates Win-Win for Both Society and International Age-Tech Companies (Published: December 9, 2021) 12.16 2021 / 【Research Topic】Epigeneron, Inc. and Center for Genomic and Regenerative Medicine, Juntendo University School of Medicine started a joint research on novel drug target discovery for neurodegenerative diseases (Published: November 24, 2021) 11.25 2021 / 【Research Topic】RIKEN’s Supercomputer Fugaku takes first place in the Graph 500 for the fourth consecutive terms (Published: November 16, 2021) 11.19 2021 / 【FBRI Topic】Grow Your Medical Business in Kobe 11.04 2021 / 【Company Topic】HACARUS and Kyoto University Jointly Develop Diagnostic Support AI for Cervical Cancer (Published: October 12, 2021) 10.29 2021 / 【Company Topic】T-ICU Co., Ltd Commences Remote ICU Support Contracted by JICA for About 10 Countries in the Oceania, Asia, Africa and Latin America Regions (Published: August 26, 2021) 10.18 2021 / 【FBRI Topic】 The Japanese MedTech & HealthTech Market 2021 10.06 2021 / 【Company Topic】 SINFONIA TECHNOLOGY CO., LTD. launched industry's first fully automated cell culture instrument with data-driven quality management (Published: September 24, 2021) 09.27 2021 / 【Research Topic】Prof. Minako Hoshi and Dr. Tomoya Sasahara of FBRI’s research was published in an iScience journal entitled “Alzheimer’s Aβ assembly binds sodium pump and blocks endothelial NOS activity via ROS-PKC pathway in brain vascular endothelial cells” (Published: September 25 2021) 09.22 2021 / 【Research Topic】 Genetic Diagnosis and Counseling at Kobe City Eye Hospital for Inherited Retinal Dystrophy was Approved by Advanced Medical Care Conference (Published: September 3, 2021) 09.14 2021 / 【FBRI Topic】 FBRI Commences Renovation for New Contract Manufacturing Facility for Cells in Order to Accelerate Development of Cell and Gene Therapy Treatments 09.14 2021 / 【Company Topic】 Evec has succeeded in developing anti-SARS-CoV-2 antibodies 09.08 2021 / 【Healthcare Topic】Kobe City Launched Eldercare Technology Implementation and Promotion Project ~ Designing the Future of Eldercare ~ 09.02 2021 / 【Company Topic】Aeras Bio, Inc. is expanding the range of application of dental pulp regenerative treatments (Published: July 19, 2021) 09.01 2021 / 【Research Topic】Kobe University established a treatment and research center for cancer photoimmunotherapy and started outpatient Illuminox® services for head and neck cancers at Kobe University Hospital International Clinical Cancer Research Center (ICCRC) (Published: August 2, 2021) 08.27 2021 / 【Company Topic】Oncolys BioPharma Inc. begin two Phase 2 clinical trials targeting neurodegenerative diseases (Published: August 16, 2021) 08.23 2021 / 【Company Topic】Carna Biosciences, Inc. announces Completion of Dosing in Phase 1 SAD Study of AS-1763 (Published: July 26, 2021) 07.28 2021 / 【FBRI Topic】Introducing the Cell Port City, gene therapy and cell manufacturing ecosystem in KBIC 07.07 2021 / 【Research Topic】RIKEN’s supercomputer FUGAKU takes first place for the three consecutive terms in four high-performance computer rankings (TOP500, HPCG, HPL-AI, Graph500) 06.24 2021 / 【FBRI Topic】FBRI is a proud partner of German Entrepreneurship Asia! 06.18 2021 / 【Company Topic】 Meiji Seika Pharma Co., Ltd. and the FBRI successfully created an antibody drug candidate for the treatment of autoimmune disease through collaborative research (Published: May 18, 2021) 06.17 2021 / 【Research Topic】Prof. Minako Hoshi of FBRI’s research on Alzheimer's disease was published in the British Journal of Pharmacology (BJP) 06.02 2021 / 【New Brochure】”Kobe Biomedical Innovation Cluster (KBIC) Business Introduction” published 05.31 2021 / 【Research Topic】Dr. Akihiko Taguchi of FRBI’s research was published in the electronic version of the American scientific journal “Stem Cells” 05.28 2021 / 【Company Topic】HACARUS Brings Sparse Modeling to Drug Discovery with Mitsubishi Tanabe Pharma (Published: May 25, 2021) 05.26 2021 / 【New Series】 “KBIC innovator interviews” ~The first featured innovator is TASUKU HONJO, M.D., Ph.D. , President of FBRI. 05.26 2021 / 【Event/Seminar】3rd KBIC Global Webinar ~ German Ecosystem and Collaboration Opportunities ~ 05.26 2021 / 【FBRI Topic】MAGIA (European Strategic Cluster Partnerships) and FBRI is collaborating with MAGIA2Market project 04.19 2021 / 【Research Topic】Dr. Daichi Inoue’s research was published in Nature Genetics: ‘Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition’, (Published: April 12, 2021) 04.14 2021 / 【Company Topic】Bacchus Bio innovation Co., Ltd. Raises $10.9M in Series A Financing and Announces Its New Management Team (Published: March 31, 2021) 04.09 2021 / 【Company Topic】Oncolys BioPharma Inc. Announces the Effect of Novel Coronavirus Infection Drug OBP-2011 on COVID-19 Variants (Published: March 23, 2021) 03.31 2021 / 【Healthcare Topic】Kobe City introduces a healthcare data coordination system for the first time in Japan 03.17 2021 / 【Research Topic】Kobe City, Rakuten Medical Japan and Kobe University to collaborate on research and development of new cancer treatments based on the Illuminox™ platform (Published: February 9, 2021) 03.09 2021 / 【Company Topic】JCR Pharmaceuticals Co., Ltd. Decided to Construct a New Plant for COVID-19 Vaccine Solution (Published: March 4, 2021) 03.01 2021 / 【Company Topic】Carna Bioscience, Inc. announced completion of PMDA review for a clinical trial notification to initiate clinical trial of AS-0141 (Published: February 22, 2021) 02.17 2021 / 【Research Topic】RIKEN’s supercomputer Fugaku will be available for shared use from March 9 (Published: February 9, 2021) 02.09 2021 / 【Research Topic】Naoki Ito, Senior Researcher at the Department of Gerontology, Laboratory of Molecular Life Science, FBRI, Received the “Best Young Investigator's Award” from the Japan Muscle Society 02.08 2021 / 【Research Topic】TreeFrog Therapeutics in partnership with QC-Stem consortium (Foundation for Biomedical Research and Innovation at Kobe and others) has received 2020 Galien Medstartup Award in “Best Collaboration in the Pharmaceutical or Biotechnology Industry” category (Published: October 27, 2020) 02.03 2021 / 【Company Topic】T-ICU Co., Ltd. Undertakes JICA’s ICU Telemedicine Support Survey Project in Developing Countries - Helping Support for COVID-19 Counter Measures with Japan Model of ICU Telemedicine - (Published: January 8, 2021) 01.29 2021 / 【Event/Seminar】2nd KBIC Global Webinar ~ Take the hints from Digital Healthcare of Denmark and Germany, apply into Innovative Medical Device Development ~ 01.28 2021 / 【Company Topic】Toray Industries, Inc. Expands LIVMOA™ Protective Clothing Lineup by Launching Versions for High-Pressure Water Applications and Cleanrooms (Published: January 13, 2021) 01.21 2021 / 【Company Topic】T-ICU Co., Ltd. raises a total of 153 million yen from Beyond Next Ventures Inc. and others (Published: January 5, 2021) 01.21 2021 / 【Company Topic】HACARUS INC. named Best Japanese Startup/SME for the French/European Market (Published: December 7, 2020) 01.15 2021 / 【Company Topic】 JCR Pharmaceuticals Co., Ltd. Signs Provisional Production Master Service Agreement with AstraZeneca Regarding Domestic Production of COVID-19 Vaccine Bulk Product (Published: December 30, 2020) 01.07 2021 / 【Research Topic】Dr. Masayo Takahashi, President, Vision Care, Inc. as part of Kobe Eye Center; Director, Laboratory for Retinal Regeneration RIKEN Center for Biosystems Dynamics Research has received The Greenberg Prize - End Blindness 2020 - Visionary Award(Published: December 28, 2020) 12.28 2020 / 【Company Topic】Kobe University and Sysmex Corporation Conducted Clinical Evaluation of the ELISPOT Method: A New Test for COVID-19 using blood - Report on T cell Immunity to SARS-CoV-2 in the Japanese Population - (Published: December 24, 2020) 12.28 2020 / 【Company Topic】Sysmex Corporation Obtains Marketing Approval for the HISCL™ IFN-λ3 Assay Kit, a Test Kit to Assist in Determining Exacerbation Risk in Novel Coronavirus (SARS-CoV-2)-Positive Patients (Published: December 23, 2020) 12.28 2020 / 【Company Topic】Oncolys BioPharma Inc. and ASAHI INTECC CO., LTD. Announces Conclusion of Capital and Business Alliance（Published: December 10, 2020） 12.17 2020 / 【Company Topic】Medicaroid Corporation jointly developed a Medicaroid Intelligent Network System (MINS) for hinotori™ surgical robot system with OPTiM Corporation and Sysmex Corporation（Published: October 26, 2020） 12.02 2020 / 【Company Topic】Sysmex Corporation Applies for Manufacturing and Marketing Approval for a SARS-CoV-2 Antigen Detection Reagent（Published：November 11, 2020） 11.24 2020 / 【Research topic】RIKEN’s supercomputer Fugaku takes first place for the two consecutive terms in four high-performance computer rankings (TOP500、HPCG、HPL-AI、Graph500) (Published: November 17, 2020) 11.24 2020 / 【Company Topic】HACARUS INC. (leading provider of explainable lightweight AI Solution) closes Series B Round - Raised 1.3 Billion Yen to date (Published: November 16, 2020) 11.24 2020 / 【Research topic】World’s First iPS Cell-derived Photoreceptor Cell Transplant Surgery Performed in Kobe (Published: October 16, 2020) 11.04 2020 / 【Company Topic】Foundation for Biomedical Research and Innovation (FBRI) in Kobe, Japan becomes first CAR-T cell therapy (Kymriah®) commercial manufacturing site in Asia 10.15 2020 / 【Company Topic】T-ICU Co., Ltd. Introduces Tele-ICU System to Medical Institutions in Kobe in Collaboration with the City of Kobe 10.12 2020 / 【Company Topic】UTAX CO., LTD. donated 5,000 washable masks to the City of Kobe 10.07 2020 / 【Company Topic】Sysmex Corporation Applies for Manufacturing and Marketing Approval for a SARS-CoV-2 Antigen Detection Reagent 09.28 2020 / 【Company Topic】Bio Palette Raises $9.5M in Series A Financing to Accelerate Development of Microbiome Therapeutics 09.24 2020 / 【Research topic】World's first clinical study begun in Kobe to transplant allogeneic iPS cell-derived retinal sheet for retinitis pigmentosa 09.14 2020 / 【Research topic】Simulation results by the supercomputer “Fugaku” announced regarding the effects of masks and ventilation for prevention of droplet transmission 09.03 2020 / 【Research topic】Dr. Daichi Inoue of FBRI won American Society of Hematology Global Research Award 08.24 2020 / 【Research topic】FBRI and Fraunhofer IME signed a Joint Research Agreement on Drug Discovery for Dementia with Japanese Pharma Company 08.11 2020 / 【Company Topic】Medicaroid Corp. received Japanese regulatory approval for the “hinotori™ Surgical Robot System”, the first made-in-Japan robotic assisted surgery system 08.07 2020 / 【Company Topic】KiSCO Co., Ltd. launched SYNCHA Spinal Endoscope System for Endoscopic Spine Surgery 08.07 2020 / 【Company Topic】Aeras Bio Inc. started the world’s first practical application of regenerative medicine using dental pulp stem cells 07.03 2020 / KBIC is introduced in the article in American magazine ”The Atlantic” 06.29 2020 / Fugaku in KBIC now the fastest supercomputer in the world 06.26 2020 / New PR movie “A New Challenge for the Kobe Biomedical Innovation Cluster– Resolving Treatment and Testing Issues in the Age of the Novel Coronavirus –” released 3.31 2020 / KBIC Portal site is newly launched 07.03 2020 / KBIC is introduced in the article in American magazine ”The Atlantic” 6.29 2020 / Fugaku in KBIC now the fastest supercomputer in the world 6.26 2020 / New PR movie “A New Challenge for the Kobe Biomedical Innovation Cluster – Resolving Treatment and Testing Issues in the Age of the Novel Coronavirus –” released 3.31 2020 / KBIC Portal site is newly launched 07.03 2020 / KBIC is introduced in the article in American magazine ”The Atlantic” 6.29 2020 / Fugaku in KBIC now the fastest supercomputer in the world 6.26 2020 / New PR movie “A New Challenge for the Kobe Biomedical Innovation Cluster – Resolving Treatment and Testing Issues in the Age of the Novel Coronavirus –” released 3.31 2020 / KBIC Portal site is newly launched